three years of REDEFINE threads, summarised so you do not have to read them
Been lurking in c/orforglipron for about 16 months and finally have something worth posting. Short version: week 70, 12.5mg, and amylin is the bit I still cannot get a straight answer on. I have read the wiki, I have read the last 3 threads, and the answers split roughly down the middle. What I actually want to know…
The evidence standard in c/vendorvetting gets called too strict about once a month, and every time, the thread ends with the complainant agreeing.
Yeah, amylin is doing different work than GLP-1.
CagriSema is a fixed combo in trials, not user-mixed
REDEFINE phase 9 readouts are interesting but 9 person amylin is different from 9 trial amylin.